FDA Investigates Potential Adult Deaths Linked to COVID-19 Vaccines

FDA's Expanded Vaccine Safety Review

• 🔍 The FDA is broadening its investigation into potential links between COVID-19 vaccines and adult deaths, expanding from an earlier focus on children.
• 🗣️ An FDA spokesperson confirmed a "thorough investigation, across multiple age groups, of deaths potentially related to Covid vaccines."

Transparency and Data Concerns

• ❓ Questions are raised about the transparency of the data used, specifically referencing the Vaccine Adverse Events Reporting System (VAERS) as voluntary and potentially unreliable without further case background analysis.
• 📈 The speaker emphasizes the need for proper scrutiny of data, stating, "I want to see the data and I want it properly scrutinized. Let us do that."

Potential Impacts of the Investigation

• ⚖️ The FDA's findings could influence public health policy and impact how vaccine providers, particularly Pfizer and Moderna, move forward.
• ⚠️ Possible outcomes include the FDA finding no link, issuing a black box warning that could increase hesitancy, or, less likely, removing the vaccine from the market.

Financial Exposure of Vaccine Companies

• 💰 Moderna and Biontech are identified as the most exposed companies, with Moderna having a lower cash cushion despite being more leveraged to vaccine sales.
• 📉 Concerns exist that a negative outcome could significantly impact revenue and financial stability for these companies.

Biotech Sector Performance and Regulatory Stability

• 🚀 Despite underlying worries, the biotech sector has shown strong performance, with significant capital raised recently.
• 🎯 A call is made for the FDA to establish clear, stable, and scientifically-based guidelines to ensure predictability for the industry.